Biostem Promotes Michael Fortunato, CPA to Chief Monetary

POMPANO BEACH, FL., October 26, 2022 (Globe Newswire) — BioStem Applied sciences Inc. (“BioStem” or the “Firm) (OTC Pink: BSEM), is a number one regenerative drugs firm targeted on the event, manufacture and use of placental derivatives. The Commercialization of Tissue Allografts introduced immediately that Michael Fortunato, CPA, has been promoted from his former controlling … Read more